Atrial Fibrillation Trial, Recruiting NCT07270757 Sponsor: Nanjing Medical University Condition: Atrial Fibrillation
Back to Atrial Fibrillation

Atrial Fibrillation Trial, Recruiting

NCT07270757
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 70 years old
  • People who are scheduled to have their first ablation procedure for atrial fibrillation (a heart rhythm condition)
  • People whose heart failure symptoms are mild or absent, meaning day-to-day activities are not significantly limited (confirm with trial site)
  • People whose heart is pumping at a normal or near-normal strength, as measured by a heart scan (confirm with trial site)

Who may not be able to join:

  • People who have serious structural problems with their heart, such as severely damaged heart valves
  • People who have a medical reason that prevents them from safely doing exercise testing or an exercise-based program
  • People who have difficulty with thinking, understanding, or memory that would prevent them from participating fully in the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8618018223427

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Nanjing Medical University
Registry
ClinicalTrials.gov
Start date
1 February 2025
Est. completion
1 February 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Peak Oxygen Uptake at 3 months; Atrial Arrhythmic Events within 90 days

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov